A Boualisina product
Sodium Valproate
We are looking forward to your inquiry.
Description and usage
Indicated for:
1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures.
2) Adjunctive therapy in the management of multiple seizure types that include absence seizures.
3) Prophylaxis of migraine headaches.
4) Acute management of mania associated with bipolar disorder.
1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures.
2) Adjunctive therapy in the management of multiple seizure types that include absence seizures.
3) Prophylaxis of migraine headaches.
4) Acute management of mania associated with bipolar disorder.
Off-label uses include:
1) Maintenance therapy for bipolar disorder.
2) Treatment for acute bipolar depression.
3) Emergency treatment of status epilepticus.
Structure
General Data
Chemical Name: Sodium 2-propylpentanoate
Sodium Valproate
Cas no.: 1069-66-5
Molecular formula: C8H15NaO2
Molecular weight: 166.2 g/mol
Reference
BP2020